Peddle, C., & MacLaren, R. (2021). Development of all-in-one CRISPR/Cas9 and CRISPRi AAV constructs to treat autosomal dominant retinitis pigmentosa.
Citación estilo ChicagoPeddle, CF, and RE MacLaren. Development of All-in-one CRISPR/Cas9 and CRISPRi AAV Constructs to Treat Autosomal Dominant Retinitis Pigmentosa. 2021.
Cita MLAPeddle, CF, and RE MacLaren. Development of All-in-one CRISPR/Cas9 and CRISPRi AAV Constructs to Treat Autosomal Dominant Retinitis Pigmentosa. 2021.
Warning: These citations may not always be 100% accurate.